Does your regenerative cell therapy have any side effects?
Regenerative cell therapy has no known side effects. However, as with any medical procedure, there are risks involved. To reduce side effects and risk, the regenerative experts at GIOSTAR Chicago use autologous regenerative cells – cells that come from your own body – during the procedure.
Is the stem cell therapy administered by GIOSTAR Chicago safe?
The regenerative cell therapy administered at GIOSTAR Chicago is safe. The standards for testing are higher than those recommended by American Association of Blood Banks (AABB), the international leader in standards and accreditation for transfusion and cellular therapies in the United States.
At a minimum, the regenerative cells used for therapies are tested for viral, bacterial, and fungal infections, as well as counted for live cells and viability quality. GIOSTAR Chicago uses the strictest standards for regenerative therapy in the world.
How quickly can you see results after the regenerative cell therapy?
You may notice a change in your health within seven days following your first regenerative cell therapy procedure. However, it takes up to 12 months after your third transplant for you to see the full benefits of the therapy.
How much does the therapy cost?
I am interested in learning more and seeing if I qualify for this therapy. What are my next steps?
Your inquiry will be routed to an educated, well-informed advocate to speak with you about the field of stem cell science. If you are seeking therapy, it is a 3 step process to determine if you are a candidate for GIOSTAR Chicago:
- Complimentary consultation to answer all your questions and discuss your needs.
- Completion of a health history form that’s reviewed by a GIOSTAR Chicago specialist.
- If you’re approved as a candidate for regenerative cell therapy, a 25% deposit is required to reserve your treatment date.
The team at GIOSTAR Chicago will answer all question respectfully and confidentially, in a timely manner.
A study by Dr. Tamir Rashid and a @KingsCollegeLon / @KCLstemcells team - published in @nature - examines the potential of "stem-cell like" HHyP cells for liver tissue regeneration, a possible alternative to transplants.
#LiverDisease #Research #StemCells
Promising breakthrough from OHSU in understanding bone disease: @rojasburke at @OHSUKnight reports on work by Dr Luiz Bertassoni and team that leverages stem cells to develop material that mimics human bone tissue.
#OHSUMedTech #Cancer #StemCells #Research